Projects funded by the NCN
Immunological and molecular characteisitics of chronic myeloid leukemia patients after stopping imatinib
2018/31/B/NZ6/03361
Keywords:
chronic myeloid leukemia imatinib
Descriptors:
- NZ6_2: Clinical immunology
- NZ5_3: Pathogenesis of human diseases
- NZ5_7: Human disease treatment
Panel:
NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology
Host institution :
Uniwersytet Medyczny w Lublinie, Wydział Lekarski
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 5
Call: OPUS 16 - announced on 2018-09-14
Amount awarded: 1 135 680 PLN
Project start date (Y-m-d): 2019-07-22
Project end date (Y-m-d): 2023-07-21
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.